CN Patent

CN101426477A — 纳米颗粒卡维地洛制剂

Assigned to Perrigo Pharma International DAC · Expires 2009-05-06 · 17y expired

What this patent protects

本发明指向具有改进的药代动学曲线、改进的生物利用度、溶解速率和效率的纳米颗粒卡维地洛组合物。在一种实施方式中，该纳米颗粒卡维地洛组合物的有效平均粒度小于约2000nm。

USPTO Abstract

本发明指向具有改进的药代动学曲线、改进的生物利用度、溶解速率和效率的纳米颗粒卡维地洛组合物。在一种实施方式中，该纳米颗粒卡维地洛组合物的有效平均粒度小于约2000nm。

Drugs covered by this patent

sodium-zirconium-cyclosilicate (SODIUM ZIRCONIUM CYCLOSILICATE)

Patent Metadata

Patent number: CN101426477A
Jurisdiction: CN
Classification: —
Expires: 2009-05-06
Drug substance claim: No
Drug product claim: No
Assignee: Perrigo Pharma International DAC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.